SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SIMIONI, Carolina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.498
AS - Asia 1.799
EU - Europa 1.699
SA - Sud America 339
AF - Africa 33
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.398
SG - Singapore 735
PL - Polonia 517
CN - Cina 502
IT - Italia 413
BR - Brasile 290
DE - Germania 219
HK - Hong Kong 161
UA - Ucraina 123
GB - Regno Unito 113
VN - Vietnam 111
TR - Turchia 89
FI - Finlandia 66
RU - Federazione Russa 59
SE - Svezia 58
CA - Canada 56
ID - Indonesia 51
MX - Messico 40
IN - India 39
FR - Francia 35
JP - Giappone 24
NL - Olanda 23
AR - Argentina 21
BD - Bangladesh 20
ZA - Sudafrica 18
BE - Belgio 16
ES - Italia 12
AT - Austria 9
EC - Ecuador 9
IQ - Iraq 9
PK - Pakistan 9
LT - Lituania 6
VE - Venezuela 6
AU - Australia 5
CZ - Repubblica Ceca 5
IR - Iran 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CO - Colombia 4
DZ - Algeria 4
HU - Ungheria 4
IE - Irlanda 4
KE - Kenya 4
PY - Paraguay 4
SA - Arabia Saudita 4
TW - Taiwan 4
AL - Albania 3
JO - Giordania 3
KR - Corea 3
UZ - Uzbekistan 3
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
CL - Cile 2
DO - Repubblica Dominicana 2
EU - Europa 2
IL - Israele 2
KG - Kirghizistan 2
PH - Filippine 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
AZ - Azerbaigian 1
CY - Cipro 1
EG - Egitto 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.376
Salva come PNG Salva come JPEG
Città #
Warsaw 515
Singapore 401
Fairfield 383
Ashburn 380
Woodbridge 280
Houston 222
Beijing 174
Chandler 172
Ferrara 167
Santa Clara 166
Seattle 157
Ann Arbor 156
Hong Kong 156
Cambridge 144
Wilmington 139
Jacksonville 128
Dallas 89
Los Angeles 70
Munich 66
Izmir 55
Milan 53
Princeton 49
Jakarta 46
Nanjing 46
New York 44
Shanghai 37
Ho Chi Minh City 32
San Diego 29
São Paulo 27
Boardman 25
Dearborn 24
Dong Ket 24
Bologna 21
Helsinki 20
Mexico City 20
Tokyo 20
Turku 19
Hanoi 18
Nanchang 18
Shenyang 18
Buffalo 17
Frankfurt am Main 17
Hefei 17
Brussels 16
Falkenstein 16
Montreal 15
Atlanta 14
Denver 14
Bengaluru 13
London 13
Phoenix 13
Rio de Janeiro 13
Montréal 12
Boston 11
Changsha 11
Chennai 11
San Francisco 11
Auburn Hills 10
Stockholm 10
Brasília 9
Columbus 9
Kunming 9
Moscow 9
Nuremberg 9
Poplar 9
Brooklyn 8
Hebei 8
Jinan 8
Johannesburg 8
Rome 8
Toronto 8
Belo Horizonte 7
Bremen 7
Chicago 7
Redwood City 7
Tianjin 7
Addison 6
Ankara 6
Council Bluffs 6
Curitiba 6
Falls Church 6
Guangzhou 6
Hangzhou 6
Lauterbourg 6
Manchester 6
Norwalk 6
Porto Alegre 6
Redmond 6
The Dalles 6
Zhengzhou 6
Amsterdam 5
Baghdad 5
Campinas 5
Des Moines 5
Dhaka 5
Hải Dương 5
Imola 5
Lappeenranta 5
Miami 5
Ottawa 5
Totale 5.135
Salva come PNG Salva come JPEG
Nome #
Targeting mTOR in Acute Lymphoblastic Leukemia 255
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 250
PHARMACOLOGICAL CHARACTERIZATION OF THE SIGNAL TRANSDUCTION PATHWAYS MODULATED BY A3 RECEPTORS IN CANCER CELLS: POSSIBLE TARGETS FOR THERAPEUTIC INTERVENTION. 230
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 225
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 222
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 222
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 219
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 218
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 217
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 206
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 204
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 200
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 195
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 190
Adenosine receptors and cancer 183
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 183
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 170
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 166
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 149
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 148
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 145
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 142
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 142
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 140
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 137
A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN CANCER CELLS 131
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 130
PI3K/Akt/mTOR Pathway in Acute Lymphoblastic Leukemia Targeted Therapies 128
Optical tissue clearing associated with 3D imaging: application in preclinical and clinical studies 126
Binding thermodynamics at the human A2B adenosine receptor. 121
Legislation to limit the environmental plastic and microplastic pollution and their influence on human exposure 119
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent AKT reactivation. 116
null 112
VEGF and IL-8 regulation by cytotoxic drugs in human melanoma cells: molecular mechanism modulated by A2B and A3 adenosine receptors 107
Micrornas patterns as potential tools for diagnostic and prognostic follow‐up in cancer survivorship 102
The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies 100
Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage 99
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation. 96
Effects of SARS-COV-2 on molecules involved in vascularization and autophagy in placenta tissues 95
null 95
Microalgae as a Nutraceutical Tool to Antagonize the Impairment of Redox Status Induced by SNPs: Implications on Insulin Resistance 91
The role of extracellular vesicles as shuttles of RNA and their clinical significance as biomarkers in hepatocellular carcinoma 91
The novel Akt inhibitor MK-2206, is cytotoxic in T-cell acute lymphoblastic leukemia: Therapeutic implications 91
A2B AND A3 ADENOSINE RECEPTORS MODULATE VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 EXPRESSION IN HUMAN MELANOMA CELLS TREATED WITH ETOPOSIDE AND DOXORUBICIN. 89
The mTOR inhibitor, RAD001, displays higher cytotoxicity in leukemias with hyperactivated PI3K/AKT/mTOR pathway 87
null 86
null 86
Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives 85
null 84
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 80
Therapeutic potential of the novel mTOR inhibitor Torin-2 to overcome AKT reactivation in B-precursor acute lymphoblastic leukemia (B-pre ALL). 74
The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy 73
Regulation of Second Messenger Systems and Intracellular Pathways. 49
Increase of VEGF and Fibronectin expression and ultrastructural alterations of intercellular junctions in a swab negative patient after SARS-COV-2 infection 34
Totale 7.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.330
Totale 37.099
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021623 0 0 0 0 0 106 67 98 46 169 69 68
2021/2022434 20 35 21 4 36 36 13 35 15 47 55 117
2022/2023467 55 36 26 42 60 49 42 31 45 30 37 14
2023/2024299 28 35 22 6 15 29 19 22 5 10 15 93
2024/20251.414 39 47 115 74 180 125 93 71 223 135 162 150
2025/20261.872 428 126 306 449 520 43 0 0 0 0 0 0
Totale 7.535